G. Grandi, Margaret Sammarini, Maria Chiara Del Savio, A. Toss, F. Facchinetti
{"title":"BRCA基因突变携带者联合激素避孕药:为什么不?","authors":"G. Grandi, Margaret Sammarini, Maria Chiara Del Savio, A. Toss, F. Facchinetti","doi":"10.1080/13625187.2019.1647335","DOIUrl":null,"url":null,"abstract":"Germline mutations in BRCA1 and BRCA2 account for a large proportion of hereditary breast and ovarian cancers. These tumour suppressor genes, respectively, located in chromosome 17q and 13q, and di...","PeriodicalId":22423,"journal":{"name":"The European Journal of Contraception & Reproductive Health Care","volume":"11 1","pages":"417 - 419"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Combined hormonal contraceptives in BRCA gene mutation carriers: why not?\",\"authors\":\"G. Grandi, Margaret Sammarini, Maria Chiara Del Savio, A. Toss, F. Facchinetti\",\"doi\":\"10.1080/13625187.2019.1647335\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Germline mutations in BRCA1 and BRCA2 account for a large proportion of hereditary breast and ovarian cancers. These tumour suppressor genes, respectively, located in chromosome 17q and 13q, and di...\",\"PeriodicalId\":22423,\"journal\":{\"name\":\"The European Journal of Contraception & Reproductive Health Care\",\"volume\":\"11 1\",\"pages\":\"417 - 419\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The European Journal of Contraception & Reproductive Health Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/13625187.2019.1647335\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European Journal of Contraception & Reproductive Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/13625187.2019.1647335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Combined hormonal contraceptives in BRCA gene mutation carriers: why not?
Germline mutations in BRCA1 and BRCA2 account for a large proportion of hereditary breast and ovarian cancers. These tumour suppressor genes, respectively, located in chromosome 17q and 13q, and di...